Parmax Pharma Announces Board Meeting for Q1 Financial Results
Parmax Pharma Ltd has scheduled a meeting of its Board of Directors to review and approve the unaudited standalone financial results for the quarter ending June 30, 2026.The Board meeting is set to take place on Friday, August 14, 2026, with the purpose of considering and approving the aforementioned quarterly financial results.
In line with internal regulations regarding insider trading, Parmax Pharma confirmed that the trading window for the company’s securities has been closed. The restriction remains in effect up to fortyeight hours following the announcement of both the standalone and consolidated financial results for the quarter ended on June 30, 2026.
Stock Price Movement
At 10:14, Parmax Pharma Ltd shares are ticking up slightly at ₹111.00, representing a 1.98% gain. The stock is currently locked and trading completely flat, holding firm at this intraday price point of ₹111.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.